Previous studies found that the expression of GPRC5D protein on the tumor cells of MM patients was specific, and, as a seven-transmembrane protein, it was difficult to detach, leading to off-target effects of TCBs [15,19]. This evidence concerns the gene GPRC5D and Miyoshi myopathy.